SWK HOLDINGS CORP - SWKH 9 01/31/27 (SWKHL) Stock Price, Quote, News and Summary

Company Profile

SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 22 full-time employees. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.

Company Info

SWK HOLDINGS CORP - SWKH 9 01/31/27

5956 Sherry Lane, Suite 650

Dallas TEXAS US

Employees: 22

Company Website: https://www.swkhold.com/

Investor Relations: http://swkhold.investorroom.com/index.php

Phone: 12142177253